Showing results (191-200 of 206) with videos related to
Sort By:
Pageof 21
Prostate Cancer|July 3, 2019
Inhibition of Prostate Cancer Cells by 4,5-Dicaffeoylquinic Acid through Cell Cycle ArrestOlivia Lodise, Ketki Patil, Igor Karshenboym, et al.Prostate Cancer|July 6, 2019
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion StatusDianne van Strijp, Christiane de Witz, Birthe Heitkötter, et al.Prostate Cancer|July 14, 2012
Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicityDavid Thomson, Sophie Merrick, Ric Swindell, et al.Prostate Cancer|June 24, 2014
Urodynamic evaluation after high-intensity focused ultrasound for patients with prostate cancerLuigi Mearini, Elisabetta Nunzi, Silvia Giovannozzi, et al.Prostate Cancer|August 18, 2012
Emerging putative biomarkers: the role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosisJames R Marthick, Joanne L DickinsonProstate Cancer|May 12, 2021
The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter StudyMohammed Jayed Alenzi, Amany A Ghazy, Diaa-Eldin TahaProstate Cancer|May 13, 2020
Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate CancerBenjamin H Lowentritt, Michael S KipperProstate Cancer|May 13, 2020
Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer PatientsBrittni M Usera, Polly Creveling, Jonathan D TwardProstate Cancer|January 15, 2026
Reliability of Negative Prostate MRI for Biopsy Decision-Making in the Male Han Chinese PopulationFangming Wang, Yan Zhang, Meng Fu, et al.Prostate Cancer|January 7, 2026
Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-TNeal D Shore, Emmanuel S Antonarakis, Jason Hafron, et al.Pageof 21